医渡科技（02158）今日盘中大涨6.27%，引发市场关注。这一涨幅与近期发布的医药工业数智化转型政策密切相关。
据悉，4月24日，国家卫健委等七部门联合印发《医药工业数智化转型实施方案(2025-2030年)》。该方案提出，到2030年，规上医药工业企业基本实现数智化转型全覆盖，数智技术融合创新能力大幅提升。方案重点布局了四大专项行动，包括数智技术赋能、数智转型推广、数智服务体系建设和数智监管提升，旨在全面提升我国医药工业的数智化转型能力。
医渡科技作为AI医疗领域的领先企业，其业务与此次政策方向高度契合。公司依托"AI医疗大脑"YiduCore，提供覆盖公共健康、临床与疾病研究、医疗管理、新药研发及健康管理等领域的AI解决方案。随着AI技术在医药行业的深入应用，预计将显著提升新药研发效率、降低生产成本，加速创新药和高端制剂突破。市场分析认为，此次政策的出台将为医渡科技等AI医疗企业带来更多发展机遇，推动整个医药产业向更高质量、更智能化的方向发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.